These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7107047)

  • 21. Pathogenesis of severe hyperoxalaemia in Crohn's disease-related renal failure on maintenance haemodialysis: successful management with pyridoxine.
    Marangella M; Vitale C; Petrarulo M; Cosseddu D; Gallo L; Linari F
    Nephrol Dial Transplant; 1992; 7(9):960-4. PubMed ID: 1328946
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma oxalate in chronic renal failure and normal subjects: methodological problems.
    Dorhout Mees EJ; Boer P
    Nephron; 1988; 48(3):256-7. PubMed ID: 3352859
    [No Abstract]   [Full Text] [Related]  

  • 23. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
    Marangella M; Petrarulo M; Mandolfo S; Vitale C; Cosseddu D; Linari F
    Nephron; 1992; 60(1):74-80. PubMed ID: 1738418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kinetics of oxalate in hemodialysis].
    Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
    Minerva Urol Nefrol; 1991; 43(3):165-9. PubMed ID: 1817340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excessive myocardial calcinosis in a chronic hemodialyzed patient.
    Zazgornik J; Balcke P; Rokitansky A; Schmidt P; Kopsa H; Minar E; Graninger W
    Klin Wochenschr; 1987 Jan; 65(2):97-100. PubMed ID: 3560789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma oxalate and creatinine and oxalate/creatinine clearance ratios in normal subjects and in primary hyperoxaluria. Evidence for renal hyperoxaluria.
    Kasidas GP; Nemat S; Rose GA
    Clin Chim Acta; 1990 Oct; 191(1-2):67-77. PubMed ID: 2073734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure.
    Tomson CR; Channon SM; Parkinson IS; Morley AR; Lennard TW; Parrott NR; Laker MF
    J Clin Pathol; 1988 Oct; 41(10):1107-13. PubMed ID: 3192733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.
    Worcester EM; Nakagawa Y; Bushinsky DA; Coe FL
    J Clin Invest; 1986 Jun; 77(6):1888-96. PubMed ID: 3711339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum oxalic acid in uremia: effect of a low-protein diet supplemented with essential amino acids and ketoanalogues.
    Barsotti G; Cristofano C; Morelli E; Meola M; Lupetti S; Giovannetti S
    Nephron; 1984; 38(1):54-6. PubMed ID: 6472531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperoxaluria and hyperoxalemia: one more concern for the nephrologist.
    Mitwalli A; Oreopoulos DG
    Int J Artif Organs; 1985 Mar; 8(2):71-4. PubMed ID: 3886558
    [No Abstract]   [Full Text] [Related]  

  • 33. Uremic levels of oxalic acid suppress replication and migration of human endothelial cells.
    Levin RI; Kantoff PW; Jaffe EA
    Arteriosclerosis; 1990; 10(2):198-207. PubMed ID: 2317157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant calcified mass in a hemodialysis patient.
    Combalia A; Munoz-Mahamud E; Cofan F
    Kidney Int; 2019 Mar; 95(3):719. PubMed ID: 30784665
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of hyperoxalaemia on factor VIII-related antigen in uremia.
    Tomson CR; Channon SM; Ward MK; Hamilton PJ; Oxley A; Laker MF
    Nephron; 1990; 54(3):276. PubMed ID: 2314548
    [No Abstract]   [Full Text] [Related]  

  • 37. Contribution of dialysis to endogenous oxalate production in patients with chronic renal failure.
    France NC; Holland PT; Wallace MR
    Clin Chem; 1994 Aug; 40(8):1544-8. PubMed ID: 8044994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma oxalate concentration in chronic renal disease.
    Boer P; van Leersum L; Hené RJ; Mees EJ
    Am J Kidney Dis; 1984 Sep; 4(2):118-22. PubMed ID: 6383028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of renal failure in the primary hyperoxalurias.
    Watts RW
    Nephron; 1990; 56(1):1-5. PubMed ID: 2234239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.